Pan A, Wang Y, Talaei M, Hu FB. Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review. Circulation. 2015;132(19):1795–1804.
González-Clemente J, Palma S, Arroyo J, Vilardell C, Caixàs A, Giménez-Palop O et al. ¿La diabetes mellitus es un equivalente de riesgo coronario? Resultados de un metaanálisis de estudios prospectivos. Revista Española de Cardiología. 2007;60(11):1167-1176.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee. JAMA. 2014;311(5): 507–520.
Levit R, Wenger N. High Risk, High Stakes: Optimizing Cardiovascular Risk Assessment in Women. Current Cardiovascular Risk Reports. 2012;6(2):176-184. Modelos predictivos de riesgo cardiovascular Burgos EA. y cols. 91
Steiropoulos P. Is There Evidence of Early Vascular Disease in Patients with Obstructive Sleep Apnoea Without Known Comorbidities? Preliminary Findings. The Open Cardiovascular Medicine Journal. 2013;6(1):61-68.
Haffner S, Lehto S, Ronnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM. 1998;339 (1998) 229–234.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106(25):3143–3421.
Rana et al. Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events. JGIM. 2016;31(4):387-393.
Daniels et al. Is Diabetes Mellitus a Heart Disease Equivalent in Women? Results From an International Study of Postmenopausal Women in the Raloxifene Use for the Heart (RUTH) Trial Circulation: Cardiovascular Quality and Outcomes. Circulation. 2013;6(2):164-170.
Standards of Medical Care. Diabetes-2016: summary of revisions. Diabetes Care. 2016;39(1):1-2.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381.
Stone N, Robinson J, Lichtenstein A, Bairey C et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. JACC. 2014;63(25):2889–2934.
Kothari V, Stevens R, Adler A, et al. UKPDS 60 risk of stroke in type 2 diabetes estimated by the UK prospective diabetes study risk engine, Stroke. 2002;33(7):1776-1781.
Van der Leeuw J, Van Dieren S, Beulens J, Boeing H, Spijkerman A, Van der Graaf Y et al. The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus. Heart.2014;101(3):222-229.
Paynter N. Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent.Archives of Internal Medicine. 2011;171(19):1712-18.
Allan GM, Nouri F, Korownyk C, Kolber MR, Vandermeer B, McCormack J. Agreement among cardiovascular disease risk calculators. Circulation. 2013;127(19):1948–1956.
Helfand M, Buckley DI, Freeman M, et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(7):496–507.
Allan G, Garrison S, McCormack J. Comparison of cardiovascular disease risk calculators. Current Opinion in Lipidology. 2014;25(4):254-265.
Graham I, D’Agostino R. Therapeutic strategies in cardiovascular risk. Glob. Heart. 2013;8(1):11–23.
Damen J, Hooft L, Schuit E, Debray T, Collins G, Tzoulaki I et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ. 2016;16;353(2416):1-11.
Khanji M, Bicalho V, van Waardhuizen C, Ferket B, Petersen S, Hunink M. Cardiovascular Risk Assessment. Annals of Internal Medicine. 2016;165(10):713.
Schargrodsky et al. The CARMELA Study. The American Journal of Medicine. 2008;121:58-65.
Cortes-Bergoderi M, Thomas R, Albuquerque F, Batsis J, Burdiat G, Perez-Terzic C et al. Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Revista Panamericana de Salud Pública. 2012;32(2):131-139.
Muñoz O, Ruiz J, Mariño A. Bustos M. Concordancia entre los modelos de SCORE y Framingham y las ecuaciones AHA/ACC como evaluadores de riesgo cardiovascular. Revista Colombiana de Cardiología. 2016;24(2): 110-116.
Assmann G. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Munster (PROCAM) Study. Circulation. 2002;105(3):310-315.
Rücker V, Keil U, Fitzgerald A, Malzahn U, Prugger C, Ertl G et al. Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts. PLoS One. 2016;11(19): e0162188.
Merry, A. H. et al. Risk prediction of incident coronary heart disease in The Netherlands:re-estimation and improvement of the SCORE risk function. SAGE Journals.2012;19(4), 840–848.
DeFilippis A, Young R, McEvoy J, Michos E, Sandfort V et al. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. European Heart Journal. 2017;38(8):598-608.
Cook N, Ridker P. Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease. Annals of Internal Medicine. 2016;165(11):786-794.
Muntner P, Colantonio L, Cushman M et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations. JAMA. 2014;311(14):1406–1415.